Home › Conditions › Ascending Cholangitis
Gastro
Ascending Cholangitis
Ascending cholangitis: bacterial infection of the biliary tree, usually from CBD stone obstruction. Charcot's triad: fever/rigors, jaundice, RUQ pain (60%). Reynold's pentad = Charcot's + hypotension + altered consciousness = severe. Tokyo Guidelines grade severity: I (mild), II (moderate), III (severe organ dysfunction). High mortality if treatment delayed.
Tokyo Guidelines (TG18)
The pathway
Recognise & grade severity
- Charcot: RUQ pain, fever/rigors, jaundice; absence does not exclude cholangitis
- Grade III: any organ dysfunction—new confusion; noradrenaline (any dose)/dopamine ≥5 micrograms/kg/min; PaO₂/FiO₂ <300; oliguria/Cr >177 µmol/L; INR >1.5; platelets <100×10⁹/L
- Grade II: any TWO of WBC >12/<4, fever ≥39°C, age ≥75, bilirubin ≥85 µmol/L, albumin <0.7×LLN, without Grade III
- Grade I: neither II nor III. Reassess and escalate clinically
IV access & resuscitation
- 2 wide-bore IV cannulae
- 250 mL crystalloid over 10–15 min, reassess; repeat if needed up to 1 L total including prior fluids; senior/critical care early
- Bloods: FBC, CRP, LFTs, U&E, lactate, coagulation, cross-match; blood cultures before antibiotics if no delay
Empirical antibiotics
- Within 1 h: piperacillin-tazobactam 4.5 g IV 8-hourly, renal-adjusted
- Severe infection may need 6-hourly dosing by trust/micro plan
- Severe penicillin allergy or ESBL risk: microbiology advice; meropenem if suitable, not for severe beta-lactam allergy
- Urgent source control; review cultures and narrow treatment
Imaging
- USS abdomen: CBD dilation (>6mm), stones, gallbladder inflammation
- MRCP if USS equivocal — best non-invasive for CBD stones
- CT if diagnosis unclear or to exclude perforation
- Avoid contrast CT in AKI unless necessary
Biliary drainage — ERCP
- Septic shock: drainage ASAP (<12 h) after initial resuscitation
- Grade III (organ dysfunction): urgent drainage, aim <24 h
- Grade II: early drainage (<48 h)
- Grade I: antibiotics; reassess and drain if not improving
- ERCP: stone extraction if stable; too unstable → stent/decompress first. PTBD if ERCP fails or is unavailable
- Cholecystectomy after recovery if fit
Post-ERCP monitoring
Post-ERCP complications: pancreatitis, perforation, haemorrhage, cholangitis worsening. Monitor: bilirubin trend (should fall), temperature, WBC. If not improving 48h after ERCP — consider residual stones, resistant organism, or biliary stricture.
Drugs
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Piperacillin-tazobactam | 4.5g 8-hourly | IV | Within 1 h in sepsis; renal-adjust. Particularly severe infection may need 6-hourly dosing by trust/micro plan. |
| Meropenem | 1g 8-hourly | IV | Resistant organisms on micro advice; renal-adjust. Not for severe beta-lactam allergy. |
| IV crystalloid | 250 mL bolus over 10–15 min | IV | Reassess perfusion, UO, lactate and lungs after each bolus; up to 1 L total including prior fluids, then senior review. Senior help early; reduce/stop if overload. |
When to escalate
- Grade III organ dysfunction → senior/critical care and GI now; urgent drainage, aim <24 h. Septic shock: drainage ASAP (<12 h) after initial resuscitation
- No response to antibiotics at 12–24h → escalate antibiotics, urgent ERCP
- ERCP not possible → percutaneous transhepatic drainage (PTD) by IR
- Developing AKI → nephrology, contrast caution
- Coagulopathy (INR >1.5) before ERCP → fresh frozen plasma, vitamin K
Reference: Tokyo Guidelines TG18 — Management of Acute Cholangitis 2018
Practise and explore
Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.